Australian Arthritis and Autoimmune Biobank Collaborative
VISION: The A3BC vision is to identify causes and cures for a wide range of inflammatory arthritic and autoimmune conditions using biobank-enabled, data-linked, collaborative, and multidisciplinary research. The A3BC will identify the biological/environmental causes and phenotypic consequences of musculoskeletal conditions, and combine these with a broad range of patient and population health datasets, to uncover unknown patterns and associations for safer, more effective and evidence-based prevention, diagnosis, treatment and prognosis strategy. The initial scope of A3BC research is to better understand biological and environmental risk factors in Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Vasculitis. Once the A3BC has established these diseases within national operations, additional conditions such as Sjogren's Syndrome, Lower Back Pain, Gout, Scleroderma and Osteoarthritis are intended for future collection, with operational maturity.
|Registered Biobank Name
|Australian Arthritis and Autoimmune Biobank Collaborative (A3BC)
|Professor Lyn March
National network. NSW Headquarters: The Institute of Bone and Joint Research (IBJR), Department of Rheumatology, Clinical Administration, Level 7C, Royal North Shore Hospital, St Leonards, NSW
Sydney, NSW, Australia
|Email for biobank inquiries
|Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.